Dr Amy Aloysi: "Clinical Trial Testing New Drug That Could Slow the Progression of Alzheimer's"
As many as 5 million Americans aged 65 and older have Alzheimer’s disease. The Mount Sinai Hospital in New York is testing a new drug aimed at slowing the progression of the disease. It’s designed to protect against loss of nerve cells in the brain. “We are absolutely hoping it will prevent cognitive decline, prevent the disease from progressing, and prevent the clinical changes that happen,” says researcher Amy Aloysi, MD. Learn more
- Dr. Amy Aloysi, Assistant Professor, Psychiatry, Neurology, Icahn School of Medicine at Mount Sinai
Additional Coverage:
WUSA TV: No Web Link Available
New Drug Is Safe and Effective in Reducing 'Off' Time in People with Parkinson's Disease
Mar 21, 2013 View All Press ReleasesDr. Sam Gandy: “Scientist: Treat Alzheimer's 20 Years Before Symptoms”
Jul 13, 2011 View All Press ReleasesStudy Reveals That Dimebolin Therapy May Contribute to Neuron Deterioration
Jan 07, 2010 View All Press ReleasesMount Sinai Researchers Find New Alzheimer's Disease Treatment Promising
Jul 12, 2009 View All Press Releases